Literature DB >> 20338497

The COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) trial: can we deliver on its promise?

Patrick T O'Gara1.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20338497     DOI： 10.1016/j.jacc.2009.11.061

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  3 in total

1.  Frequency, predictors, and consequences of crossing over to revascularization within 12 months of randomization to optimal medical therapy in the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial.

Authors:  John A Spertus; David J Maron; David J Cohen; Paul Kolm; Pam Hartigan; William S Weintraub; Daniel S Berman; Koon K Teo; Leslee J Shaw; Steven P Sedlis; Merril Knudtson; Mihaela Aslan; Marcin Dada; William E Boden; G B John Mancini
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2013-07-09

Review 2.  Recent advances in the management of chronic stable angina II. Anti-ischemic therapy, options for refractory angina, risk factor reduction, and revascularization.

Authors:  Richard Kones
Journal:  Vasc Health Risk Manag       Date:  2010-09-07

3.  Chart review of acute myocardial infarction at a district hospital in KwaZulu-Natal, South Africa.

Authors:  Roland Chetty; Andrew Ross
Journal:  Afr J Prim Health Care Fam Med       Date:  2016-03-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.